Propranolol Hydrochloride Extended-release Capsules — Class II drug recall D-160-2013
Terminated recall by Upsher Smith Laboratories, Inc., reported 2013-02-20, distributed in FL, NJ. Failed Dissolution Test Requirements
| Recall number | D-160-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Upsher Smith Laboratories, Inc., Maple Grove, MN, United States |
| Recall initiated | 2012-11-20 |
| Classified | 2013-02-08 |
| Reported by FDA | 2013-02-20 |
| Terminated | 2013-07-12 |
| Distributed | FL, NJ |
| Quantity | 60 bottles |
| Reason classes | specification failure |
| NDC | 00245-0085-11 |
| Lot numbers | 308198 |
| Expiration dates | 2014-03 |
Product
Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9
Reason for recall
Failed Dissolution Test Requirements
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-160-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.